Table 2.
Variable | CIFN group (n = 71) | IFN-alpha group (n = 68) |
ALT normalization, n (%) | 38 (53.5) | 41 (60.3) |
Loss of HBV-DNA, n (%) | 18 (25.4) | 14 (20.6) |
HBeAg/anti-HBe seroconversion, n (%) | 10 (14.1) | 15 (22.1) |
Loss of HbeAg, n (%) | 10 (14.1) | 7 (10.3) |
Complete response, n (%) | 5 (7.0) | 5 (7.4) |
Partial response, n (%) | 25 (35.2) | 23 (33.8) |
CIFN, consensus interferon; IFN, interferon